Detalhe da pesquisa
1.
Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial.
Ann Rheum Dis
; 80(4): 509-517, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199274
2.
Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Arthritis Rheum
; 63(1): 212-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20954190
3.
The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Arthritis Rheumatol
; 71(11): 1824-1834, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207169
4.
Idiopathic inflammatory myopathy: treatment options.
Curr Rheumatol Rep
; 10(4): 321-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18662513
5.
Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules.
Mol Immunol
; 44(9): 2370-7, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17113648
6.
Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.
Mol Immunol
; 43(8): 1109-15, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16115686
7.
Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a.
Clin Immunol
; 127(1): 56-65, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18201931